Related Experiment Video

Updated: Jun 15, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

The AMPK-FoxO3A axis as a target for cancer treatment

Fulvio Chiacchiera1, Cristiano Simone

  • 1Laboratory of Signal-dependent Transcription; Department of Translational Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.

Cell Cycle (Georgetown, Tex.)
|March 2, 2010
PubMed

Insights

The AMPK/FoxO3A pathway, crucial for cell metabolism and stress response, remains active in cancer cells. Targeting this axis offers potential therapeutic strategies for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cellular Metabolism
  • Cancer Biology

Background:

  • FoxO proteins are key transcription factors regulating metabolism and tumor suppression.
  • AMP-activated protein kinase (AMPK) controls cellular energy balance.
  • The interplay between AMPK and FoxO3A is critical for cellular adaptation to stress.

Purpose of the Study:

  • To review the regulatory mechanisms and functional roles of the AMPK-FoxO3A pathway.
  • To explore the activation of this pathway in human cancer cells under metabolic stress.
  • To highlight the therapeutic potential of modulating the AMPK-FoxO3A axis in cancer.

Main Methods:

  • Review of existing literature on FoxO proteins, AMPK, and cellular metabolism.
  • Analysis of studies demonstrating AMPK/FoxO3A pathway induction in cancer cells.
  • Discussion of the downstream effects of FoxO3A activation, including autophagy and cell death.

Main Results:

  • The AMPK/FoxO3A pathway is inducible in colorectal and ovarian cancer cells upon p38α inhibition.
  • FoxO3A activation initially promotes autophagy for energy conservation.
  • Persistent stress leads to FoxO3A-induced autophagic cell death.

Conclusions:

  • The AMPK-FoxO3A axis acts as a critical energy sensor and regulator of cell fate.
  • This pathway's inducibility in cancer cells presents a promising therapeutic target.
  • Pharmacological targeting of the AMPK-FoxO3A pathway could offer novel cancer treatment strategies.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...